PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11536370-2	2001	We hypothesize that alterations in the TGF-beta pathway contribute to differential sensitivity of mice to the colon carcinogen azoxymethane (AOM).	Azoxymethane	127-139	transforming growth factor, beta 1	Mus musculus	39-47	
12720300-0	2003	Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.	Azoxymethane	64-76	transforming growth factor, beta 1	Mus musculus	28-60	
11536370-2	2001	We hypothesize that alterations in the TGF-beta pathway contribute to differential sensitivity of mice to the colon carcinogen azoxymethane (AOM).	Azoxymethane	141-144	transforming growth factor, beta 1	Mus musculus	39-47	
31734229-7	2020	AOM-treated mice had increased TSP-1 and TGFbeta1 mRNA and protein expression in the liver.	Azoxymethane	0-3	transforming growth factor, beta 1	Mus musculus	41-49	
10938397-0	2000	Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.	Azoxymethane	105-117	transforming growth factor, beta 1	Mus musculus	14-46	
10938397-2	2000	We postulated that TGF-beta1 and TbetaR-II alterations may also be involved in mouse colon tumorigenesis induced by the chemical carcinogen, azoxymethane (AOM).	Azoxymethane	141-153	transforming growth factor, beta 1	Mus musculus	19-28	
31734229-11	2020	Taken together, TSP-1 is an activator of TGFbeta1 signaling during AOM-induced acute liver failure and contributes to both liver pathology and HE progression.	Azoxymethane	67-70	transforming growth factor, beta 1	Mus musculus	41-49